The 12-Item Hypoglycemia Impact Profile (HIP12): psychometric validation of a brief measure of the impact of hypoglycemia on quality of life among adults with type 1 or type 2 diabetes

• Published in: BMJ open diabetes research & care Vol. 10; no. 4; p. e002890
• Main Authors: Broadley, Melanie, Chatwin, Hannah, Søholm, Uffe, Amiel, Stephanie A, Carlton, Jill, De Galan, Bastiaan E, Hendrieckx, Christel, McCrimmon, Rory J, Skovlund, Søren E, Pouwer, Frans, Speight, Jane, Tack, Cees, Galan, Bastiaan de, Amiel, Stephanie, Choudhary, Pratik, Pieber, Thomas, Mader, Julia, Evans, Mark, Renard, Eric, Thorens, Bernard, Heller, Simon, Brennan, Alan, Pedersen-Bjergaard, Ulrik, McCrimmon, Rory, Haardt, Jakob, Ibberson, Mark, Sparacino, Giovanni, Colhoun, Helen, Gough, Stephen, Milicevic, Zvonko, Kazemi, Mahmood, Cohen, Ohad, Dutta, Sanjoy, Robert, Dominique, Wolf, Wendy, Sullivan, Sean
• Format: Journal Article
• Language: English
• Published: London American Diabetes Association 01-08-2022; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Closed loop systems; COVID-19; Diabetes; Glucose; Hypoglycemia; Insulin; Pandemics; Part time employment; psychometrics; psychosocial issues; Psychosocial Research; Qualitative research; Quality of life; Quantitative psychology; Social networks
• ISSN: 2052-4897; 2052-4897
• DOI: 10.1136/bmjdrc-2022-002890

IntroductionThe aim of this study was to determine the psychometric properties of the 12-Item Hypoglycemia Impact Profile (HIP12), a brief measure of the impact of hypoglycemia on quality of life (QoL) among adults with type 1 (T1D) or type 2 diabetes (T2D).Research design and methodsAdults with T1D (n=1071) or T2D (n=194) participating in the multicountry, online study, ‘Your SAY: Hypoglycemia’, completed the HIP12. Psychometric analyses were undertaken to determine acceptability, structural validity, internal consistency, convergent/divergent validity, and known-groups validity.ResultsMost (98%) participants completed all items on the HIP12. The expected one-factor solution was supported for T1D, T2D, native English speaker, and non-native English speaker groups. Internal consistency was high across all groups (ω=0.91–0.93). Convergent and divergent validity were satisfactory. Known-groups validity was demonstrated for both diabetes types, by frequency of severe hypoglycemia (0 vs ≥1 episode in the past 12 months) and self-treated episodes (<2 vs 2–4 vs ≥5 per week). The measure also discriminated by awareness of hypoglycemia in those with T1D.ConclusionsThe HIP12 is an acceptable, internally consistent, and valid tool for assessing the impact of hypoglycemia on QoL among adults with T1D. The findings in the relatively small sample with T2D are encouraging and warrant replication in a larger sample.